Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 74, Issue 12, Pages 2263-2282Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-017-2490-4
Keywords
Integrins; Extracellular matrix; Atherosclerosis; Inflammation; Proliferation; Migration
Categories
Funding
- National Institute of Health [R01 HL098435]
- American Heart Association [15GRNT25560056]
- intramural Malcolm Feist Pre-doctoral Fellowship
- American Heart Association Pre-doctoral Fellowship [17PRE33440111]
Ask authors/readers for more resources
Atherosclerosis, a chronic lipid-driven inflammatory disease affecting large arteries, represents the primary cause of cardiovascular disease in the world. The local remodeling of the vessel intima during atherosclerosis involves the modulation of vascular cell phenotype, alteration of cell migration and proliferation, and propagation of local extracellular matrix remodeling. All of these responses represent targets of the integrin family of cell adhesion receptors. As such, alterations in integrin signaling affect multiple aspects of atherosclerosis, from the earliest induction of inflammation to the development of advanced fibrotic plaques. Integrin signaling has been shown to regulate endothelial phenotype, facilitate leukocyte homing, affect function, and drive smooth muscle fibroproliferative remodeling. In addition, integrin signaling in platelets contributes to the thrombotic complications that typically drive the clinical manifestation of cardiovascular disease. In this review, we examine the current literature on integrin regulation of atherosclerotic plaque development and the suitability of integrins as potential therapeutic targets to limit cardiovascular disease and its complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available